Stage II Breast Cancer Active Not Recruiting Phase 2 Trials for Exemestane (DB00990)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01831076Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 TumorsTreatment